Skip to Content

Investor Update

Basel, 21 September 2009

Reminder: Roche Investor Science Event: Conference Call from ECCO ESMO 2009

Friday, September 25th, 2009

We are pleased to invite you to a Conference Call to discuss new data on Roche’s oncology products and pipeline being presented during the joint 15th Congress of the European Cancer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO), which runs from September 20th – September 24th, 2009 in Berlin, Germany.

Conference Call Date/Time:

Friday, 25th September, 2009

  • 02.30 pm to 03.30 pm Central Europe Summer time CEST (Berlin)
  • 01.30 pm to 02.30 pm British Summer time BST (London)
  • 08.30 am to 09.30 am Eastern Daylight time EDT (United States)

Highlights:

  • Sandra Horning, M.D., Senior Vice President and Global Head of Clinical Development Oncology/Hematology and Head of the Disease Biology Leadership Team, Advances in cancer treatment
  • Varun Nanda, Global Product Strategy Head Oncology, Real-life experience with Avastin (BEAT, BRiTE, SAiL and ATHEN)
  • Philippe Bishop, M.D., Vice President, Clinical Development, Avastin, Genentech,
  • AVANT safety data - CRC, melanoma (BEAM phase II study)Niko Andre, M.D., Medical Director Avastin Franchise, Avastin BOXER study, PLX4032 in advanced melanoma (phase I extension results)
  • Stefan Frings, M.D., HER2 Franchise Leader, Herceptin in gastric cancer (ToGA, HER2 expression subgroup analysis), Xeloda in adjuvant colon cancer (no 16968 study)

The conference call will consist of a presentation, followed by a Q&A session (with live access to speakers). Presentation slides will be posted prior to the event on the Roche IR website www.roche.com/ir_agenda.

Dial in to the conference 10-15 min prior to the scheduled start using the following numbers:

+41 (0) 91 610 56 00 (Europe and ROW)
+44 (0) 207 107 06 11 (UK)
+1 (1) 866 291 4166 (USA-toll free)

A replay of the conference call will be available one hour after the conference call, for 48 hours.

Access is by dialing:

+41 91 612 43 30 (Europe and ROW)
+44 207 108 62 33 (UK)
+1 (1) 866 416 25 58 (USA)

Listeners will be asked to enter the ID 12472 followed by the # sign

Alternatively a live audio webcast can be accessed via http://ir.roche.com.

We hope that you can participate in this event.